AvantGuard’s AVA-003 compound offers a proactive solution against antimicrobial resistance, targeting pathogens with sustained activity, addressing the urgent need for innovative infection prevention in healthcare and conflict zones. AvantGuard’s new antiseptic compound, called AVA-003, offers proactive infection prevention through sustained antimicrobial activity. Unlike conventional antibiotics, AVA-003 demonstrates equivalent activity against antibiotic-susceptible and resistant bacteria/fungi via selective microbial cell wall targeting. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Balta, I.; Lemon, J.; Gadaj, A.; Cretescu, I.; Stef, D.; Pet, I.; Stef, L.; McCleery, D.; Douglas, A.; Corcionivoschi, N. The interplay between antimicrobial resistance, heavy metal pollution, and the role of microplastics.